Logo

AlphaGene Appoints Zabriskie and Hochberg To Board of Directors

Nov 21, 1998
Premium

WOBURN, Mass.--Emerging genomics company AlphaGene here announced the appointment of John Zabriskie and Steven Hochberg to its board of directors last week. Zabriskie, former president and CEO of Pharmacia and Upjohn, is chairman and president of NEN Life Science Products, a supplier of reagents for labeling and detection of DNA, RNA, and proteins. Hochberg is a partner and managing director of ProMed Management, a private investment group involved in significant healthcare and biomedical financings.

Filed under

Informatics
Breaking News
The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.